TOMS RIVER – As we transition into cold and flu season, CenExel Toms River continues to support efforts that highlight the importance of immunizations—for both individual well-being and community-wide protection.
Vaccines remain one of the most effective tools in preventing the spread of infectious diseases. Each approved vaccine is the result of rigorous scientific a rigorous scientific process focused on safety, efficacy, and accessibility. CenExel Toms River plays a vital role in this process by conducting clinical research studies that help shape the future of immunization.
“At CenExel Toms River, we recognize that vaccines are not just a scientific achievement—they’re a cornerstone of public health,” said Anna Brocco, PharmD, Chief Operating Officer at CenExel Toms River. “Our team is proud to contribute to the research that makes these life-saving tools possible, especially as we enter a season where immunization is more important than ever.”
CenExel Toms River is proud to contribute to this ongoing effort, supporting clinical research that informs the development of vaccines for both longstanding illnesses and emerging infectious diseases. Through collaboration with medical professionals and research sponsors, the site helps advance knowledge that benefits public health on a global scale.
To learn more about the role of clinical research in vaccine development—including ongoing studies focused on adults aged 50 and older, visit CenExel.com/TomsRiverNJ or call 732-908-1510.
